Summary: Rats received unilateral injections of ibotenic acid (12 fLg) or vehicle in the ventromedial globus pallidus to lesion the primary source of cortical cholinergic in nervation. At 3 or 28-32 days postinjection, the regional cerebral metabolic rate for glucose (rCMRg1u) was mea sured by the 2-deoxY-D-[14C]glucose technique in nine cortical areas, the anterior thalamus, and the dorsal hip pocampus. Effects of oxotremorine (0
Summary: Rats received unilateral injections of ibotenic acid (12 fLg) or vehicle in the ventromedial globus pallidus to lesion the primary source of cortical cholinergic in nervation. At 3 or 28-32 days postinjection, the regional cerebral metabolic rate for glucose (rCMRg1u) was mea sured by the 2-deoxY-D-[14C]glucose technique in nine cortical areas, the anterior thalamus, and the dorsal hip pocampus. Effects of oxotremorine (0.1 mg/kg i.p.) on rCMRgl U in these areas were assessed in ibotenic acid lesioned and sham-treated rats. Significant effects of ibo tenic acid injections and hemispheric asymmetries in rCMRgiu were observed in all cortical areas (p � 0.05), but not in the anterior thalamus or hippocampus. Cortical rCMRgiu generally was lower in the lesioned hemisphere 3 days after ibotenic acid injections, but not after sham Alzheimer's disease is characterized by marked but relatively selective decrements in the presyn aptic markers for cholinergic neurons in the cere bral cortex and hippocampal formation. Deficits have been observed in the activities of choline ace tyltransferase (EC 2.3.1.6) (Davies and Maloney, 1976; Perry et aI., 1977; White et aI., 1977) , acetyl cholinesterase (EC 3.1.1. 7) (Perry et al., 1978) , and acetylcholine synthesis (Sims et aI., 1981) . The brain in Alzheimer's disease also shows a marked loss of large cholinergic neurons in Nissl-stained sections of the nucleus basalis of Meynert (White house et aI., 1982) , a population of neurons in the basal forebrain (Gorry, 1963) .
Cells of the nucleus basalis are acetylcholines terase reactive in histochemical assays (Mesulam treatments . Hemispheric asymmetries were not apparent 28-32 days after pallidal lesions. Oxotremorine produced significant effects in the frontoparietal cortex and anterior thalamic nuclei. In the frontoparietal cortex, rCMRgiu was 32% lower in the ibotenate-lesioned hemisphere as com pared with the contralateral hemisphere. Oxotremorine did not eliminate hemispheric asymmetry, but increased rCMRgiu in the lesioned frontoparietal cortex by 38%. Re sults support the views that cortical metabolic decre ments in Alzheimer's disease are due in part to loss of subcortical cholinergic innervation and that muscarinic agonists may partially reverse these decrements. Key Words: Acetylcholine-Cerebral cortex-Cerebral glu cose utilization-Ibotenic acid-Nucleus basalis-Oxo tremorine.
and Van Hoesen, 1976; Parent et aI., 1979) , appear to contain choline acetyltransferase (Davies and FeisuIlin, 1982) , and project directly to the cerebral cortex (Divac, 1975; Kievit and Kuypers, 1975; Me sulam and Van Hoesen, 1976) . These observations support the hypothesis that changes in the nucleus basalis of Meynert are important to the cholinergic abnormalities in Alzheimer's disease (Whitehouse et aI., 1982) . In the rat, the nucleus basalis mag nocellularis, which is composed of a sheet of cells lying at the ventromedial aspect of the globus pal lidus (Gorry, 1963) , is believed to be homologous to the nucleus basalis of Meynert in the primate brain (Johnston et aI., 1979; Lehmann et al., 1980) . Le sions placed in this nucleus of rats and primates, produced by injections of ibotenic acid, a neuro toxic analogue of L-glutamic acid (Schwarcz et aI., 1979) , result in selective reductions in cholinergic presynaptic markers of the ipsilateral cerebral cortex (Johnston et aI., 1979; Struble et aI., 1984) . Thus, ibotenic acid lesions of the nucleus basalis may serve as a model for the neurochemical se quelae of Alzheimer's disease (Coyle et aI., 1981) .
Clinical in vivo studies of global cerebral blood flow and metabolism have demonstrated cerebral metabolic deficits in patients with Alzheimer's dis ease (Freyhan et aI., 1951; Lassen et aI., 1960; Obrist et al., 1970; Simard et aI., 1971; Hagberg and Ingvar, 1976; Yamaguchi et aI., 1980) . Consistent with this observation, the regional cerebral meta bolic rate for glucose (rCMR g 1u), measured by pos itron emission computed tomography with USF]2-deoxy-2-fluoro-D-glucose, is decreased in the neo cortex of the brain in Alzheimer's disease (Ferris et aI., 1983; Foster et aI., 1983) . This impairment in glucose utilization does not appear to result from a disruption of the oxidative metabolic capacity of cerebral cortical cells, since biopsy samples ob tained from the cortices of patients with Alz heimer's disease exhibit enhanced glucose con sumption when incubated in vitro (Sims et aI., 1981) .
This discrepancy between in vivo glucose utili zation and in vitro capacity to metabolize glucose raises the question of whether the reductions in ce rebral metabolic activity observed in Alzheimer's disease patients might not result from the functional degeneration of cortical cholinergic afferent sys tems. To test this hypothesis, we have used the 2-deoxY-D-[1-14C]glucose ([14C]DG) method (Sokoloff et aI., 1977) to examine the effects on rCMR g iu of lesions of the cholinergic projections to the rat ce rebral cortex. Lesions were produced by unilateral injections of ibotenic acid into the ventromedial globus pallidus. Because of the suggestion that di rectly acting cholinomimetic agents might amelio rate cognitive deficits such as those seen in Alz" heimer's disease (Sitaram et aI., 1978) , we also as sessed the effects of oxotremorine, a cholinergic muscarinic receptor agonist (Levy and Michel-Ber, 1965) , on the neocortical rCMR g iu in rats with le sions in the ventromedial globus pallidus. Previous studies have indicated that oxotremorine produces a dose-dependent stimulation of neocortical rCMR g iu in rats (Dam et aI., 1982) . An abstract of this work has been published (London et aI., 1983) .
METHODS
Studies were completed on 33 male Fischer-344 rats, purchased from the Charles River Breeding Laboratories (Wilmington, MA, U.S.A.). The rats were shipped when they were 10 weeks of age, and were maintained until they reached a body weight of 235 g, usually when they were 12 weeks old. Pallidal injections Were made at this time. The rats were housed in a thermally controlled (25°C), light-cycled (0700 h on, 1900 h off) vivarium and fed laboratory chow (NIH-07 formula) ad libitum.
Stereotaxic injections
Rats were anesthetized with an intraperitoneal injec tion of 40 mg/kg pentobarbital, and were placed in a small animal stereotaxic apparatus (David Kopf Instruments, Tu junga, CA, U.S.A.). Injections into the left nucleus basalis magnocellularis in the ventromedial globus pal lidus were made through a 30-gauge stainless steel Ham ilton cannula connected to a lO-fd Hamilton microsyringe via polyethylene tubing. The infusion needle was posi tioned at the following coordinates: 0.3 mm posterior to the bregma, 2.9 mm lateral to the midline, and 7.2 mm ventral to the pial surface. Either 0.8 fLl of 100 mM Tr is buffer, pH 7.7, containing 12 fLg of ibotenic acid (Regis Chemical Co., Milwaukee, WI, U.S.A.) or 0.8 fLl of the vehicle only (sham treatment) was infused through the cannula over 1 min. The cannula was left in place for another minute, and then was removed. The scalp was apposed with 9-mm autoclips, and the rat was returned to the vivarium for 3 (acute treatment) or 28-32 (chronic survival) days before additional studies.
Preparation for [14C]DG studies
Under ether anesthesia, rats were prepared with in dwelling femoral venous and arterial catheters, as de scribed previously (Sokoloff et aI., 1977; Dow-Edwards et aI., 1981) . Following surgery, they were placed in a sound-insulated wooden box (62 x 46 x 43 cm) where body temperature was monitored with a rectal thermo probe and regulated by a feedback device (Y SI Indicating Controller Model 73ATA; Yellow Springs Instruments, Yellow Springs, OH, U.S.A.) that activated heating wires on the roof of the box when body temperature fell below 36°C (London et aI., 1981) . The rats were allowed to re cover for 4 h before further treatments.
Drug treatments
Control rats received isotonic saline, 0.9% (wt/vol) NaCI (1 mIlkg body weight subcutaneously 22 min before [14C]DG and intraperitoneally 2 min before [14C]DG). The other rats received atropine methylbromide (1 mg/kg s.c. 22 min before [14C]DG) and oxotremorine (0.1 mg/kg i.p. 2 min before [14C]DG). The purpose of the atropine methylbromide pretreatment was to block peripheral muscarinic effects of oxotremorine. This dose blocks lacrimation and diarrhea but not tremor in 3-month-old Fischer-344 rats treated with 0.1 or 0.7 mg/kg oxotremo rine (Dow-Edwards et aI., 1981; Dam et aI., 1982) .
Measurement of rCMR giu
The rCMRg1u was determined in various regions of the cerebral cortex, hippocampus, and anterior thalamic nu clei, as previously described (Sokoloff et aI., 1977) . Rats were killed by a pentobarbital overdose (60 mg in I ml i.v.) 50 min after the injection of [14C]DG (125 fLCi/kg body weight i.v.). Brains were removed and frozen in 2-methylbutane (Fisher Scientific Co., Silver Spring, MD, U.S.A.) at -60°C. Frozen 20-fLm sections were obtained by cutting the brains on a Cryo-Cut II cryostat (American Optical Co., Buffalo, NY, U.S.A.) maintained at -20 to -22°C. Sections were thaw-mounted onto glass cover slips, and regional brain radioactivity was determined by quantitative autoradiography (Sokoloff et aI., 1977) . Areas of the cerebral cortex were designated according to Krieg (1946) . Adjacent sections were stained with cresyl violet for histological examination.
The rCMRg1u was calculated from brain and plasma ra-dioactivities and plasma glucose concentrations using rate and lumped constants for the transport and phos phorylation of [14C]DG as given by Sokoloff et al. (1 977) . Calculations were made with an operational equation that allows variations in the arterial plasma glucose concen tration during the experimental period (Savaki et aI., 1980) . During the first 10 min after the injection of [14C]DG, glucose concentrations were elevated by 34 ± 4% (mean ± SEM) over the initial value of 165 ± 6.0 mg/lOO m!. At 50 min after the injection of the radiotraccr, the concentrations were elevated by 62 ± 9.4%.
Histological examination
Cresyl violet-stained sections were used to verify the cerebral injection site in each rat. Any rat that showed evidence of an injection outside the ventromedial globus pallidus or of neuronal loss in the cerebral cortex was excluded.
Statistical analyses
Data were analyzed using a 2 (pallidal injection: ibo tenate, sham) x 2 (drug: oxotremorine, saline) x 2 (re covery: acute, chronic) x 2 (hemisphere: injected, con tralateral) factorial analysis of variance, with repeated measures on the last factor (Winer, 1971) , using the BMDP/P2V program (Dixon and Brown, 1979) . Post hoc comparisons between mean values of rCMRgiu in injected and contralateral hemispheres and between values in oxotremorine-and saline-treated rats were made using F tests for simple main effects (Winer, 1971) . Because of unequal sample sizes (n) among treatment groups, it was necessary to derive a harmonic mean estimate of n for each comparison (Winer, 1971) . The criterion for statis tical significance was taken as p "" 0.05.
RESULTS

Histology of the ibotenate lesion
As previously described (Johnston et aI., 1981) , ibotenic acid-injected rats showed a sphere of neu ronal degeneration involving the ventral globus pal lidus ( Fig. O . Most animals also incurred some damage in the lateral preoptic area and to a lesser extent in the lateral hypothalamus and anterior striatum. However, any rat with a lesion that ex tended into the amygdala was excluded. There was no obvious damage to the cerebral cortex.
Effects of ibotenate lesion on rCMR giu
The mean values of rCMR g iu in 12 brain regions are shown in Ta ble 1. The results of the analysis of variance are shown in Ta ble 2, which indicates the significance of the main effects and interactions.
In general, cortical rCMR g iu was lower in the le sioned hemisphere acutely after ibotenic acid injec tions (25 :±: 1.8% decrement, mean ± SEM for 9 cortical regions, comparing the injected and contra lateral hemispheres separately in saline-and oxo tremorine-treated groups), and to a much lesser ex tent after sham injections (7.9 ± 0.6% decrement). In addition, hemispheric asymmetries observed 3 days after pallidal injections no longer were ap parent 28-32 days postinjection, demonstrating re covery. These effects were observed in auto radio grams of brain sections from rats subjected to the [14C]DG procedure 3 or 28-32 days after ibotenic acid injection (Fig. 2) . Three days after placement of the lesion, rCMR g iu was decreased in the corpus striatum and nucleus accumbens as well as the cortex of the lesioned hemisphere. Asymmetries in cortical rCMR g iu were not seen 28-32 days post injection.
The main effect of hemispheric asymmetry, re flecting lower rCMR g iu in the injected hemisphere as compared with the contralateral, was significant in all of the cortical areas, but not in the anterior nuclei of the thalamus or in the dorsal hippo campus. Similarly, the main effect of the pallidal injection, reflecting lower rCMR g iu in ibotenate-Ie sioned rats than in sham-injected rats, was signifi cant in all of the cortical areas, but not in the an terior thalamic nuclei. The effect of pallidal injec tion was also significant in the dorsal CA l area of the hippocampus, reflecting a lower rCMR g iu in ibo tenate-Iesioned animals given oxotremorine. A sig nificant main effect for recovery, associated with higher rCMR g iu in rats 28-32 days after pallidal in jection than 3 days postinjection, was seen in the frontal (area 10), somatosensory (areas 3-1-2 and 4-6), and auditory regions of the cerebral cortex. The main effect of drug treatment, reflecting a greater increase in rCMR g iu in oxotremorine-treated rats than in saline-injected rats, was significant in only two brain regions, the frontoparietal cortex (area 14) and the anterior nuclei of the thalamus.
Effects of oxotremorine on rCMR giu
Although oxotremorine tended to increase rCMR g iu in most cortical regions of rats given acute pallidal ibotenate or sham treatments and in rats 28-32 days after sham injections (Table 1) , a sig nificant main effect of oxotremorine on rCMR g iu was seen only in the frontoparietal cortex (area 14) and the anterior thalamic nuclei ( Table 2 ). In the frontoparietal cortex, oxotremorine did not elimi nate the hemispheric asymmetry owing to the acute ibotenate treatment. However, it increased rCMR g iu in the lesioned frontoparietal cortex by 38%, so that the level was virtually the same as that in the cortex contralateral to the lesion in rats not treated with oxotremorine.
The observations in the cerebral cortex were manifested in significant interactions ( Table 2) . Per haps the best examples of these general patterns were obtained with the data from the frontal (area 10) and frontoparietal (area 14) regions of the ce- "Tabulated numbers are the F ratios generated from the data for each main effect and interaction. These values were compared with F( 1,25) at p "" 0.05 and p "" 0.01. The following interactions were tested but were not significant (p > 0. (5):
pallidal injection; R, recovery; D, drug; H, hemisphere.
, p "" 0.0 1.
'p "" 0.05.
2A 2B
rebral cortex, where there were significant three way interactions involving hemisphere (injected versus contralateral), pallidal injection (ibotenate versus sham), and recovery (acute versus chronic). Because these interactions did not involve systemic drug treatment (oxotremorine, saline), they were analyzed combining the data from oxotremorine and saline-treated rats (Table 3 ). In the frontal cortex (area 10) and the frontoparietal cortex (area 14), rCMR g iu was significantly reduced by 27 and 31 %, respectively, in the ibotenate-injected hemi sphere compared with the contralateral side 3 days postinjection. In corresponding sham-injected ani mals, there was no hemispheric asymmetry in the frontal cortex (area 10), and a small but significant 8.8% reduction in the frontoparietal cortex of the injected hemisphere. There was no hemispheric asymmetry in either brain region 28-32 days post injection.
The differences between the effects of ibotenic acid and sham injections on hemispheric asymme tries in rCMR g iu were illustrated by significant two way interactions. Significant interactions between pallidal injection and hemisphere were obtained in the frontal (area 8) and somatosensory (areas 3-1-2 and 4-6) regions of the cerebral cortex. These were examined, collapsing across the effects of oxotremorine and recovery (Table 4) . In each of these brain regions, rCMR g iu was significantly re duced by 14-16% in the ibotenate-Iesioned hemi sphere as compared with the contralateral. Sham injections produced no significant hemispheric asymmetries in area 8 of the frontal cortex or in areas 3 -1-2 of the somatosensory cortex, and pro- Frontal cortex Acute 60 ± 4.4 (7)" (area 10) Chronic 82 ± 7.5 (10) Frontoparietal cortex Acute 68 ± 8.4 (7)" (area 14)
Chronic 85 ± 5.6 (10) hemisphere 82 ± 5.5 82 ± 6.6 98 ± 9.2 90 ± 6.5 hemisphere 82 ± 11 (6) 103 ± 6.0 (10) 88 ± 9.9 (6)" III ± 7.2 (10) 87 ± 11 102 ± 6.01 97 ± 10 113 ± 8. 8
Each value (,."mol/100 g/min) is the mean ± SEM for the number of animals indicated in parentheses. Because drug treatment (oxotremorine. saline) was not a factor in the I x R x H interaction. data from oxotremorine-treated rats were combined with those from saline-treated rats. See Table 2 duced only a minor 5.8% but significant decrement in rCMR g iu of areas 4-6 of the somatosensory cortex.
Evidence that recovery diminished or eliminated decrements in cortical rCMR g iu after pallidal injec tion was obtained from significant two-way inter actions between recovery and hemisphere. Such in teractions were seen in the data from the frontal (area 8) , somatosensory (areas 3-1-2 and 4-6) , au ditory (areas 40-41), visual (areas 17-18) , and peri rhinal (area 13) regions of the cerebral cortex. These were analyzed, collapsing across effects of pallidal injection (ibotenate, sham) and drug (oxo tremorine, saline) ( Table 5) . Three days after pal lidal injections, the rCMR g iu in each of these brain regions was significantly reduced by 12-21% in the injected hemisphere as compared with the contra lateral side. In contrast, rats examined 28-32 days postinjection showed no hemispheric asymmetries in these brain regions, except in areas 4-6 of the somatosensory cortex, where rCMR g iu was signifi cantly lower in the injected hemisphere by only 3.8%.
Oxotremorine treatment also was a factor in volved in various significant interactions ( Table 2) . The significant pallidal injection x drug interaction in the perirhinal cortex was due to a 30% higher rCMR g iu in oxotremorine (vs. saline)-treated rats given sham injections in the globus pallidus. This difference was not seen in corresponding rats in jected with ibotenic acid. In the CA l region of the dorsal hippocampus, the interaction reflected a 31 % lower rCMR g iu in ibotenic acid-injected rats treated with oxotremorine, as compared with corre sponding saline-treated rats, but no oxotremorine effect in sham-injected rats. In the medial cortex, there was a three-way interaction involving drug, recovery, and hemisphere. This interaction was due to a 26% elevation of rCMR g iu in the hemisphere contralateral to the pallidal injection among rats of the chronic group but not the acute group (data from ibotenic acid-and sham-injected rats com bined). A significant injection x drug x hemi sphere interaction in the CA 3 region of the dorsal hippocampus reflected a significant enhancement of rCMR g iu in sham-injected rats but not in rats with ibotenate lesions. Among the sham-injected rats, oxotremorine treatment was associated, in the con tralateral hemisphere, with a 40% increase relative to saline treatment, whereas the increase in the in jected hemisphere was only 27%. Each value (,."mol/100 g/min) is the mean ± SEM for the number of animals indicated in parentheses. Because systemic drug treatment (oxotremorine, saline) and recovery (acute. chronic) were not factors in the I x H interaction, data from animals assigned to these treatment groups were combined. See Table 2 for abbreviations.
a Significantly different from contralateral hemisphere. p � 0.05. Each value (fLmoll100 g/min) is the mean ± SEM for the number of animals indicated in paren theses. Because pallidal injection (ibotenate, sham) and systemic drug treatment (oxotremorine, sa line) were not factors in the H x R interaction, data from animals assigned to these treatment groups were combined. See Table 2 of this observation is limited by the fact that this method has not been validated in the lesioned brain (Kelly et aI., 1982) . However, cortical rCMRg1u dec rements that occur 3 days after ibotenate injection reflect deficits in cortical function inasmuch as rCMRg1u is an index of oxidative metabolism and thereby cerebral function. Decreases in cortical rCMRg1u in lesioned rats indicate that loss of sub cortical cholinergic innervation can produce cor tical metabolic decrements. The present observa tions, therefore, support the hypothesis that neu ronal loss in the nucleus basalis of Meynert could be responsible, at least in part, for neocortical rCMRg1u decrements in Alzheimer's disease. Previous reports have indicated that neurotoxic lesions of the rat nucleus basalis magnocellularis reduce choline acetyltransferase activity in frontal, temporal, and parietal cortical areas, but not in the occipital cortex or dorsal hippocampus (Johnston et aI., 1979, 198 1; Lehmann et aI., 1980; Flicker et aI., 1983) . This distribution of effects on choline ace tyltransferase corresponds roughly with the effects on rCMRg1u in the present study. Consistent with no reported decrements in choline acetyltransferase in the hippocampal formation, there were no signifi cant hemispheric asymmetries in the rCMRg1u of this region. However, the ibotenate lesion was as sociated with ipsilateral decreases in the rCMRg1u of all cortical regions assayed. The affected areas included the visual, perirhinal, and medial regions of the cortex. In addition to the reported lack of effect of nucleus basalis lesions on choline acetyl transferase in the occipital cortex, there is no evi dence for an innervation of these cortical regions J Cereb Blood Flow Metabol, Vol. 4, No.3, 1984 from the nucleus basalis. Therefore, it is possible that rCMRg1u decrements in these regions are sec ondary to effects in other cortical areas with which they are connected. However, these rCMRg1u ef fects also could reflect a lesion of unidentified basal forebrain pathways innervating the visual, peri rhinal, and medial cortical regions. Alternatively, de creased rCMRg1u in the medial and occipital cortex could be due to a lesion of the nucleus of the hor izontal limb of the diagonal band, the source of an occipital cortical basal forebrain cholinergic projec tion, which is near the nucleus basalis and could have been lesioned (McKinney et aI., 1983) . An other possible source of decreased rCMRg1u in the cortex is damage to the rostral striatum and globus pallidus by the ibotenate injection. Lesion of these brain regions could alter cortical function through basal ganglia-thalamo-cortical pathways. The rCMRg1u decrements in the striatum may reflect de creased activity in corticostriatal afferents as well as some direct damage of the rostral striatum by the ibotenate injection.
At 28-32 days after placement of the ibotenate lesion, there were no longer significant asymmetries in rCMRg1u' This was surprising because of a pre vious report of no recovery in choline acetyltrans ferase of the frontoparietal cortex at 5 weeks after pallidal ibotenate injection (McKinney and Coyle, 1982) . However, in the same study, there was a complete recovery in the density of muscarinic ace tylcholine receptors, as measured by the binding of [ 3 H]quinuclidinyl benzilate in the frontoparietal cortex. In another study, unilateral nucleus basalis lesions produced marked decrements in sodium-de-pendent high affinity choline uptake and choline acetyltransferase in the neocortex (Wenk and Olton, 1984) . Choline uptake returned to control values within 4 weeks, as choline acetyltransferase gradually increased, reaching normal levels after 3 months. Ta ken together, these observations, which indicate extensive plasticity and recovery over time, are inconsistent with the apparent lack of re covery in Alzheimer's disease. It is noteworthy that all of these studies were performed in rats that were � 3 months of age at the time of the lesion. Given that recovery from brain damage is determined to some extent by the age of the individual at the time of the lesion (Isaac and Baker, 1963; Te uber, 1975) , it would be of interest to assess recovery from ibo tenate lesions of the nucleus basalis in sensescent rats.
Oxotremorine effects on rCMR g iu provided no ev idence for a denervation supersensitivity in chron ically lesioned rats. Previously, assays of the fron toparietal cortex 5 weeks after pallidal ibotenate le sion demonstrated an increase in the density of high affinity muscarinic agonist binding sites and a small but significant increase in the percentage of the total specific muscarinic binding associated with these sites (McKinney and Coyle, 1982) . These observa tions suggested the oxotremorine might be more po tent in enhancing rCMR g iu in chronically lesioned rats than in acutely lesioned ones. However, oxo tremorine had no greater effect 1 month after the ibotenate lesion than 3 days after the lesion. Fur thermore, it was no more effective in the lesioned hemisphere than in the contralateral hemisphere.
In addition to the aforementioned neurochemical and metabolic effects, ibotenate lesions of the nu cleus basalis also produce behavioral sequelae (Lo Conte et aI., 1982; Flicker et aI., 1983) . Lesioned rats demonstrate deficits in two-way shuttle box avoidance learning (Lo Conte et aI., 1982) , in ac quisition of a one-way active avoidance response, and in the retention of a passive avoidance response (Flicker et aI., 1983) . However, behavioral deficits were observed �3 weeks after placement of the le sions, whereas rCMR g iu defects were no longer ap parent 28-32 days after ibotenate injection. This discrepancy indicates that rCMR g iu in the resting state may not be as sensitive an index of functional integrity as behavioral measures. In this regard, normal senescence in resting rats and human sub jects is not associated with rCMR g iu decrements (London et aI., 1981; Duara et aI., 1983) , but is ac companied by performance decrements in learning and memory tests (Goodrick, 1968; Arenberg, 1978) . Nonetheless, it is possible that cortical rCMR g iu defects could be manifested in animals while subjected to behavioral challenge 1 month after ibotenate lesion.
